Evidence supporting the use of: Polyunsaturated Fat
For the health condition: Peripheral Neuropathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Polyunsaturated fats (PUFAs), particularly omega-3 fatty acids such as alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), have been investigated for their role in supporting or treating peripheral neuropathy, especially diabetic neuropathy. The scientific rationale stems from their anti-inflammatory and neuroprotective properties. Several animal studies have shown that supplementation with omega-3 PUFAs can reduce nerve damage, improve nerve conduction, and decrease neuropathic pain behaviors. Human clinical evidence is limited but suggestive: a few small-scale randomized controlled trials have reported improvements in neuropathic symptoms and nerve function in diabetic patients supplemented with omega-3 fatty acids. For example, a 2017 pilot study published in Diabetes Care found that high-dose omega-3 PUFA supplementation over one year improved small nerve fiber regeneration in patients with type 1 diabetes. However, meta-analyses and systematic reviews conclude that the overall quality of evidence is low, with more robust and larger trials needed to confirm efficacy. The use of general polyunsaturated fats (not specifically omega-3s) for neuropathy is less well-supported. In summary, there is preliminary scientific evidence, but it is not strong or definitive, and current recommendations are cautious.

More about Polyunsaturated Fat
More about Peripheral Neuropathy

Products containing Polyunsaturated Fat

We currently have no products on Vitabase that contain this ingredient.